Phase I study of SJP-0118 in healthy elderly (once a daily and twice a daily dosing study)

Trial Profile

Phase I study of SJP-0118 in healthy elderly (once a daily and twice a daily dosing study)

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jul 2016

At a glance

  • Drugs SJP 0118 (Primary)
  • Indications Blepharitis; Infectious conjunctivitis; Ocular inflammation
  • Focus Adverse reactions
  • Sponsors Senju Pharmaceutical
  • Most Recent Events

    • 28 Jul 2016 Status changed from not yet recruiting to completed.
    • 17 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top